Pharmabiz

Otsuka submits NDA for centanafadine with US FDA to treat ADHD in children, adolescents and adults

Otsuka submits NDA for centanafadine with US FDA to treat ADHD in children, adolescents and adults: Princeton, New Jersey Wednesday, November 26, 2025, 18:00 Hrs [IST] Otsuka Phar ...
Pharmabiz

Sovereign Pharma unveils high-volume ampoule isolator line

Our Bureau, Mumbai Wednesday, November 26, 2025, 17:55 Hrs [IST] Sovereign Pharma, a part of the Dadachanji Group of Co ...
Pharmabiz

Pharma, MedTech & hospitals outperform Nifty 50 in one, three year period, says Equirus Group study

Pharma, MedTech & hospitals outperform Nifty 50 in one, three year period, says Equirus Group study: Our Bureau, New Delhi Wednesday, November 26, 2025, 17:45 Hrs [IST] The NSE He ...
Pharmabiz

Arth by Emcure launches “Invest in Iron” campaign with MS Dhoni on World Iron Deficiency Day

Arth by Emcure launches “Invest in Iron” campaign with MS Dhoni on World Iron Deficiency Day: Our Bureau, Mumbai Wednesday, November 26, 2025, 17:40 Hrs [IST] Arth by Emcure, ...
Pharmabiz

Metropolis Healthcare unveils 8th edition of its flagship CSR initiative: 'MedEngage Scholarship Programme'

Metropolis Healthcare has introduced the 8th edition of its annual ‘MedEngage Scholarship Programme 2025-26.’ This year, the initiative will support 350 medical students across India through ...
Pharmabiz

Reuse of single-use medical devices takes center stage at 2025 Medicine & Law Convention, call for India specific regulations

Reuse of single-use medical devices takes center stage at 2025 Medicine & Law Convention, call for India specific regulations: Our Bureau, Bengaluru Wednesday, November 26, 2025, ...
Pharmabiz

CBC India soon to launch excipient business under new identity “Ingredients & Packaging Solutions”

CBC India will soon unveil its next big step—the launch of its excipient business under its new identity, ‘Ingredients & Packaging Solutions’. This milestone marks more than just growth--it represents ...
Pharmabiz

Avantor receives 2025 Edison Patent Award for sustainable viral inactivation technology

Avantor receives 2025 Edison Patent Award for sustainable viral inactivation technology: Radnor, Pennsylvania Wednesday, November 26, 2025, 17:00 Hrs [IST] Avantor, Inc., a leadin ...
Pharmabiz

NICE recommends next generation immunotherapy for blood cancer

NICE recommends next generation immunotherapy for blood cancer: United Kingdom Wednesday, November 26, 2025, 16:00 Hrs [IST] The National Institute for Health and Care Excellence ...
Pharmabiz

Chugai & Biomy ink MoU for joint development of AI-based cancer pathology diagnostic support programme

Chugai & Biomy ink MoU for joint development of AI-based cancer pathology diagnostic support programme: Tokyo Wednesday, November 26, 2025, 15:00 Hrs [IST] Chugai Pharmaceutical C ...
Pharmabiz

Zydus & RK Pharma ink exclusive licensing and commercialization agreement for novel 505(b)(2) product of supportive oncology treatment for USA market

Zydus & RK Pharma ink exclusive licensing and commercialization agreement for novel 505(b)(2) product of supportive oncology treatment for USA market: Our Bureau, Mumbai Wednesday ...
Pharmabiz

European Commission approves Sanofi & Regeneron’s Dupixent to treat moderate-to-severe chronic spontaneous urticaria

European Commission approves Sanofi & Regeneron’s Dupixent to treat moderate-to-severe chronic spontaneous urticaria: Paris Wednesday, November 26, 2025, 14:00 Hrs [IST] The Eur ...